GL1X · GenesisL1 explorer

Research workbench

HIV protease (pr) dimer in closed form with pepstatin in active site and fragment 1F1 in the OUTSIDE/TOP of flap

Analyse HIV protease (pr) dimer in closed form with pepstatin in active site and… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4EJD
Type
protein
Length
203 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease; Pepstatin
EC
3.4.23.16
UniProt
P12499
Ligands
IVA, 1F1

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 55% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProtease (EC 3.4.23.16)protein997% helix, 56% strandP12499
CPepstatinprotein50% helix, 40% strand—

Ligands and binding sites

  • IVA · Isovaleric acid · ligand · chains A, C
  • 1F1 · 1H-indole-6-carboxylic acid · ligand · chains A
  • BME · Beta-mercaptoethanol · additive · 3 copies · chains A, B
  • GOL · Glycerol · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Interfaces

3 interfaces between chains.

  • A–B · 1865 Ų buried · 37 hydrogen bonds · protein-protein
  • B–C · 461 Ų buried · 8 hydrogen bonds · protein-protein
  • A–C · 436 Ų buried · 6 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 3 covalent, 2 modified (additive adduct, nonstandard, covalent ligand).

Compared structures

  • 4EJD · HIV Protease (PR) dimer in closed form with pepstatin in active site and fragment 1F1 in… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.